Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B cell Lymphoma

Overview of attention for article published in Clinical Cancer Research, April 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog

twitter: 11 X users
bluesky: 1 Bluesky user

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 11 X posts from 11 X users, with an upper bound of 9,365 followers.

RT @JhaveriKhushali: 🚨Hot off the press 🚨 A lesser-known vulnerability in CAR T-cell therapy: Sarcopenia. New in CCR @AACR Predicts ↑ NR…

#Clin_Cancer_Res IF:10.0 Prospective study (n=83) showed CAR T-cell therapy for DLBCL associated with sarcopenia (50% baseline) and reduced OS (10.5 vs 34.3mo; P=0.006). Muscle loss linked to NRM. PMID:40238583 https://t.co/GDr3FmjTqQ

RT @JhaveriKhushali: 🚨Hot off the press 🚨 A lesser-known vulnerability in CAR T-cell therapy: Sarcopenia. New in CCR @AACR Predicts ↑ NR…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.